The Indian geriatric medicine market is projected to witness a considerable CAGR of 8.1% during the forecast period. The major factors contributing to the growth of the market include the increasing geriatric population and rising prevalence of cardiovascular diseases (CVDs). The country has one of the largest population bases across the globe; therefore, the geriatric population is also rising at a considerable rate in the country.
Moreover, the global market players are expanding their reach in India, owing to the favorable government policies for the entrants of the foreign companies. Therefore, considerable growth can be expected in the geriatric medicine market in India during the forecast period. Furthermore, the rising disposable income and reach of government to the underprivileged groups for health services are some other factors that will offer growth opportunities to the market during the forecast period.
The geriatric medicine market is classified on the basis of therapeutics and conditions. Based on therapeutics, the market is segmented into analgesic, anticoagulant, antihypertensive, antidiabetic, and others. Based on the condition, the market is segregated into CVDs, diabetes, neurological, cancer, respiratory, and others. Among these conditions, the CVDs segment contributes significantly to the market. The dominance of the segment is backed by the significant patient pool of CVDs across the globe. With the rise in age, the development of CVDs increases subsequently. Therefore, a huge market is covered by CVDs medicines in the geriatric medicine market.
The India geriatric medicine market is influenced by product development and advancements conducted by the market players. Some of the global key players of the geriatric medicine market include Aurobindo Pharma, Ltd. Mankind Pharma, Cipla Ltd., Sun Pharmaceuticals Industries Ltd., Pfizer Inc., Johnson & Johnson Services Inc., Eli Lilly and Co., Boehringer Ingelheim GmbH, and Amgen Inc. These players are playing a significant role in the growth of the geriatric medicine market by providing various products and adopting several strategies such as merger and acquisition, partnerships and collaboration, technological development, and others.
Research Methodology
The market study of the India geriatric medicine market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
Secondary sources include:
The report is intended for drug manufacturers, pharmaceutical & biopharmaceutical companies, research institutes, academic institutes, industry associates & experts, government organizations, regulatory bodies, and other market participants for overall market analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.
Market Segmentation:
The Report covers:
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Market Determinants
3.1. Motivators
3.2. Restraints
3.3. Opportunities
4. Market Segmentation
4.1. India Geriatric Medicine Market by Therapeutic
4.1.1. Analgesic
4.1.2. Anticoagulant
4.1.3. Antihypertensive
4.1.4. Antidiabetic
4.1.5. Others (Statins and Antipsychotic)
4.2. India Geriatric Medicine Market by Condition
4.2.1. Cardiovascular Diseases (CVDs)
4.2.2. Diabetes
4.2.3. Neurological
4.2.4. Cancer
4.2.5. Respiratory
4.2.6. Others (Arthritis and Osteoporosis)
5. Company Profiles
5.1. Abbott Laboratories Inc.
5.2. Amgen Inc.
5.3. Astellas Pharma Inc.
5.4. Aurobindo Pharma Ltd.
5.5. Boehringer Ingelheim GmbH
5.6. Cipla Ltd.
5.7. Eli Lilly and Co.
5.8. GlaxoSmithKline PLC
5.9. Johnson & Johnson Services Inc.
5.10. Mankind Pharma
5.11. Merck & Co., Inc.
5.12. Novartis AG
5.13. Pfizer Inc.
5.14. Sun Pharmaceutical Industries Ltd.
5.15. Teva Pharmaceutical Industries Ltd.
1. INDIA GERIATRIC MEDICINE MARKET RESEARCH AND ANALYSIS BY THERAPEUTIC, 2019-2026 ($ MILLION)
2. INDIA GERIATRIC MEDICINE MARKET RESEARCH AND ANALYSIS BY CONDITION, 2019-2026 ($ MILLION)
1. INDIA GERIATRIC MEDICINE MARKET SIZE, 2019-2026 ($ MILLION)
2. INDIA GERIATRIC MEDICINE MARKET SHARE BY THERAPEUTIC, 2019 VS 2026 (%)
3. INDIA GERIATRIC MEDICINE MARKET SHARE BY CONDITION, 2019 VS 2026 (%)